HLA-G and Recurrent Pregnancy Loss

Placentation is an immunological compromise where maternal immune system cells and trophoblastic cells interact to reach an equilibrium condition. Although the cross talk between the two systems is complex and not completely understood, Human Leukocyte Antigen G (HLA-G), expressed on trophoblastic c...

Full description

Bibliographic Details
Main Authors: Greta Barbaro, Annalisa Inversetti, Martina Cristodoro, Carlo Ticconi, Giovanni Scambia, Nicoletta Di Simone
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/3/2557
_version_ 1797624338320457728
author Greta Barbaro
Annalisa Inversetti
Martina Cristodoro
Carlo Ticconi
Giovanni Scambia
Nicoletta Di Simone
author_facet Greta Barbaro
Annalisa Inversetti
Martina Cristodoro
Carlo Ticconi
Giovanni Scambia
Nicoletta Di Simone
author_sort Greta Barbaro
collection DOAJ
description Placentation is an immunological compromise where maternal immune system cells and trophoblastic cells interact to reach an equilibrium condition. Although the cross talk between the two systems is complex and not completely understood, Human Leukocyte Antigen G (HLA-G), expressed on trophoblastic cell surfaces, seems to be one of the main molecules involved in the modulation of both local and systemic maternal immune response. The prevalence of recurrent pregnancy loss (RPL), probably underestimated, is 5% of all women who achieve pregnancy, and about 40–60% percent of RPL cases are unexplained. There is an immunological analogy between allograft rejection and miscarriage, and the purpose of this review is to describe how the HLA-G pathway alterations are involved in disrupting the immunologic balance and in increasing the risk of recurrent pregnancy loss.
first_indexed 2024-03-11T09:40:58Z
format Article
id doaj.art-851694f71c044938804c5cfc45af75af
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T09:40:58Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-851694f71c044938804c5cfc45af75af2023-11-16T16:59:00ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-01-01243255710.3390/ijms24032557HLA-G and Recurrent Pregnancy LossGreta Barbaro0Annalisa Inversetti1Martina Cristodoro2Carlo Ticconi3Giovanni Scambia4Nicoletta Di Simone5Dipartimento di Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico (I.R.C.C.S.), L. go A. Gemelli 8, 00168 Roma, ItalyDepartment of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072 Milano, ItalyDepartment of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072 Milano, ItalyDipartimento di Scienze Chirurgiche, Ginecologia e Ostetricia, Università di Torvergata, 00168 Roma, ItalyDipartimento di Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico (I.R.C.C.S.), L. go A. Gemelli 8, 00168 Roma, ItalyDepartment of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072 Milano, ItalyPlacentation is an immunological compromise where maternal immune system cells and trophoblastic cells interact to reach an equilibrium condition. Although the cross talk between the two systems is complex and not completely understood, Human Leukocyte Antigen G (HLA-G), expressed on trophoblastic cell surfaces, seems to be one of the main molecules involved in the modulation of both local and systemic maternal immune response. The prevalence of recurrent pregnancy loss (RPL), probably underestimated, is 5% of all women who achieve pregnancy, and about 40–60% percent of RPL cases are unexplained. There is an immunological analogy between allograft rejection and miscarriage, and the purpose of this review is to describe how the HLA-G pathway alterations are involved in disrupting the immunologic balance and in increasing the risk of recurrent pregnancy loss.https://www.mdpi.com/1422-0067/24/3/2557HLA-Grecurrent pregnancy losstrophoblastplacentation
spellingShingle Greta Barbaro
Annalisa Inversetti
Martina Cristodoro
Carlo Ticconi
Giovanni Scambia
Nicoletta Di Simone
HLA-G and Recurrent Pregnancy Loss
International Journal of Molecular Sciences
HLA-G
recurrent pregnancy loss
trophoblast
placentation
title HLA-G and Recurrent Pregnancy Loss
title_full HLA-G and Recurrent Pregnancy Loss
title_fullStr HLA-G and Recurrent Pregnancy Loss
title_full_unstemmed HLA-G and Recurrent Pregnancy Loss
title_short HLA-G and Recurrent Pregnancy Loss
title_sort hla g and recurrent pregnancy loss
topic HLA-G
recurrent pregnancy loss
trophoblast
placentation
url https://www.mdpi.com/1422-0067/24/3/2557
work_keys_str_mv AT gretabarbaro hlagandrecurrentpregnancyloss
AT annalisainversetti hlagandrecurrentpregnancyloss
AT martinacristodoro hlagandrecurrentpregnancyloss
AT carloticconi hlagandrecurrentpregnancyloss
AT giovanniscambia hlagandrecurrentpregnancyloss
AT nicolettadisimone hlagandrecurrentpregnancyloss